Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  European Journal of Cell Biology

• Publication date

  2009-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejcb.2008.05.003PMID 19058874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A MAPK-positive Feedback Mechanism for BLR1 Signaling Propels Retinoic Acid-triggered Differentiation and Cell Cycle Arrest*

  2008influential reference
• Targeting MEK1/2 blocks osteoclast differentiation, function and cytokine secretion in multiple myeloma

  2007cited by this paper
• Raf‐1 signaling is required for the later stages of 1,25‐dihydroxyvitamin D3‐induced differentiation of HL60 cells but is not mediated by the MEK/ERK module

  2006influential reference
• AKT Pathway is Activated by 1,25-Dihydroxyvitamin D3 and Participates in its Anti-Apoptotic Effect and Cell Cycle Control in Differentiating HL60 Cells

  2006cited by this paper
• p 53-independent Induction of WAF 1 / CIP 1 in Human Leukemia Cells Is Correlated with Growth Arrest Accompanying Monocyte / Macrophage Differentiation 1

  2006cited by this paper
• 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice.

  2005cited by this paper
• Mitogen-induced Rapid Phosphorylation of Serine 795 of the Retinoblastoma Gene Product in Vascular Smooth Muscle Cells Involves ERK Activation*

  2004cited by this paper
• A Novel Retinoic Acid-Responsive Element Regulates Retinoic Acid-Induced BLR1 Expression

  2004influential reference
• 1 alpha,25-dihydroxyvitamin D3 transrepresses retinoic acid transcriptional activity via vitamin D receptor in myeloid cells.

  2004cited by this paper
• The Retinoblastoma Protein and Cell Cycle Control Review

  2004cited by this paper
• Regulation of Raf-Akt Cross-talk

  2002cited by this paper
• Cell Proliferation and CD11b Expression Are Controlled Independently during HL60 Cell Differentiation Initiated by 1,25α-Dihydroxyvitamin D3 or All-trans-Retinoic Acid

  2001cited by this paper
• Cell proliferation and CD11b expression are controlled independently during HL60 cell differentiation initiated by 1,25 alpha-dihydroxyvitamin D(3) or all-trans-retinoic acid.

  2001cited by this paper
• Evidence that activation of MEK1,2/erk1,2 signal transduction pathway is necessary for calcitriol-induced differentiation of HL-60 cells.

  2001cited by this paper
• Activation of extracellular signal‐regulated kinases (ERKs) defines the first phase of 1,25‐dihydroxyvitamin D3‐induced differentiation of HL60 cells

  2001cited by this paper
• Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery.

  2001cited by this paper
• 1α,25-Dihydroxyvitamin D3–Induced Myeloid Cell Differentiation Is Regulated by a Vitamin D Receptor–Phosphatidylinositol 3-Kinase Signaling Complex

  1999cited by this paper
• Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.

  1999cited by this paper
• 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1).

  1999cited by this paper
• Cellular survival: a play in three Akts.

  1999cited by this paper
• Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth.

  1998cited by this paper
• Changes in antigen expression on differentiating HL60 cells treated with dimethylsulphoxide, all-trans retinoic acid, alpha1,25-dihydroxyvitamin D3 or 12-O-tetradecanoyl phorbol-13-acetate.

  1998cited by this paper
• Stimulation of phosphorylation of mitogen-activated protein kinase by 1alpha,25-dihydroxyvitamin D3 in promyelocytic NB4 leukemia cells: a structure-function study.

  1998cited by this paper
• Stimulation of Phosphorylation of Mitogen-Activated Protein Kinase by 1α,25-Dihydroxyvitamin D3 in Promyelocytic NB4 Leukemia Cells: A Structure-Function Study.

  1998cited by this paper
• Stable binding to E 2 F is not required for the retinoblastoma protein to activate transcription , promote differentiation , and suppress tumor cell growth

  1997cited by this paper
• 1,25-Dihydroxyvitamin D3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells.

  1997influential reference
• Effects of 1 alpha,25-dihydroxyvitamin D3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U937 cells: role in cell differentiation, activation and phagocytosis.

  1997cited by this paper
• Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells.

  1996influential reference
• Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.

  1996cited by this paper
• The nuclear receptor superfamily: the second decade.

  1995cited by this paper
• Structure-function relationships in the vitamin D endocrine system.

  1995cited by this paper
• p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation.

  1995cited by this paper
• Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells.

  1995cited by this paper
• 1,25-Dihydroxyvitamin D3 suppresses cell growth, DNA synthesis, and phosphorylation of retinoblastoma protein in a breast cancer cell line.

  1995cited by this paper
• The retinoblastoma protein and cell cycle control.

  1995cited by this paper
• Late dephosphorylation of the RB protein in G2 during the process of induced cell differentiation.

  1994cited by this paper
• Expression of activated RAF accelerates cell differentiation and RB protein down-regulation but not hypophosphorylation.

  1994cited by this paper
• All-trans retinoic acid and 1 alpha,25-dihydroxyvitamin D3 co-operate to promote differentiation of the human promyeloid leukemia cell line HL60 to monocytes.

  1994cited by this paper
• Identification of a vitamin D-response element in the rat calcidiol (25-hydroxyvitamin D3) 24-hydroxylase gene.

  1994cited by this paper
• Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53.

  1994cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• Interaction of retinoic acid and vitamin D3 analogs on HL-60 myeloid leukemic cells.

  1993cited by this paper
• Transforming growth factor-beta inhibits phosphorylation of the retinoblastoma susceptibility gene product in human monocytic leukemia cell line JOSK-I.

  1992cited by this paper
• Identification of a 1,25-dihydroxyvitamin D3-response element in the 5'-flanking region of the rat calbindin D-9k gene.

  1992cited by this paper
• Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling

  1992cited by this paper
• Synergistic effect of retinoic acid and 1,25-dihydroxyvitamin D3 on the differentiation of the human monocytic cell line U937.

  1991cited by this paper
• The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer.

  1990cited by this paper
• Vitamin D: metabolism and biological actions.

  1984cited by this paper
• Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): a morphologic, phenotypic, and functional analysis.

  1984cited by this paper
• 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells

  1984cited by this paper
• Vitamin D metabolites change the phenotype of monoblastic U937 cells.

  1983cited by this paper
• Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol.

  1983cited by this paper
• 1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60).

  1982cited by this paper
• The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins).

  1982cited by this paper
• Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.

  1981cited by this paper
• Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia.

  1979cited by this paper

• Therapeutic implications of vitamin D in leukemia: mechanistic and clinical perspectives

  2025cites this paper
• Combination of triciribine and p38 MAPK inhibitor PD169316 enhances the differentiation effect on myeloid leukemia cells

  2024cites this paper
• Identification of triciribine as a novel myeloid cell differentiation inducer

  2024cites this paper
• Unveiling the Promising Role of Substance P/Neurokinin 1 Receptor in Cancer Cell Proliferation and Cell Cycle Regulation in Human Malignancies.

  2024cites this paper
• Analysis of networks constructed from edges with positive z-scores

  2022cites this paper
• Kinase Inhibitors and Interferons as Other Myeloid Differentiation Inducers in Leukemia Therapy

  2021cites this paper
• Vitamin D and Lung Cancer; Association, Prevention, and Treatment

  2020cites this paper
• Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis

  2019cites this paper
• RAF Kinase Inhibitor Protein in Myeloid Leukemogenesis

  2019cites this paper
• Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways

  2018cites this paper
• The Physiological/Pathophysiological Significance of Vitamin D in Cancer, Cardiovascular Disorders and Beyond.

  2017cites this paper
• Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer

  2016cites this paper
• Vitamin D Control of Hematopoietic Cell Differentiation and Leukemia

  2015cites this paper
• Ursolic acid induces U937 cells differentiation by PI3K/Akt pathway activation.

  2014cites this paper
• Protective cardiovascular and renal actions of vitamin D and estrogen.

  2013cites this paper
• Chinese a Nti鄄 Cancer a Ssociation

  2013cites this paper
• TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid.

  2012cites this paper
• Application of vitamin D and derivatives in hematological malignancies.

  2012cites this paper
• Vitamin D: potential in the prevention and treatment of lung cancer.

  2012cites this paper
• Effects of vitamin D on inflammation and oxidative stress in airway epithelial cells

  2012influential citation
• A112, a tamibarotene dimethylaminoethyl ester, may inhibit human leukemia cell growth more potently than tamibarotene

  2012cites this paper
• Vitamin D effects on differentiation and cell cycle

  2011cites this paper
• Protein arginine deiminase 4: a target for an epigenetic cancer therapy

  2011cites this paper
• Hydrogen peroxide induces cell cycle arrest in cardiomyoblast H9c2 cells, which is related to hypertrophy.

  2011cites this paper
• Chapter 88 – Hematological Malignancy

  2011cites this paper
• MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia

  2011cites this paper
• Homéostasie du fer et traitement différenciant des leucémies aigües myéloblastiques

  2010cites this paper
• Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy.

  2010cites this paper
• Inhibition of mTORC1 by RAD001 (everolimus) potentiates the effects of 1,25-dihydroxyvitamin D(3) to induce growth arrest and differentiation of AML cells in vitro and in vivo.

  2010cites this paper
• Cadmium ions promote monocytic differentiation of human leukemia HL-60 cells treated with 1α,25-dihydroxyvitamin D3

  2010cites this paper
• Lysophosphatidic Acid Induces MDA-MB-231 Breast Cancer Cells Migration through Activation of PI3K/PAK1/ERK Signaling

  2010cites this paper
• Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation.

  2009cites this paper
• Interplay between signalling pathways mediates 1,25alpha-dihydroxyvitamin D3-driven monocytic differentiation--JNKs are important.

  2009cites this paper